Funding agencies: This study was supported by grants from the Canadian Institutes for Health Research (CIHR, MOP-81321). S.M. held a doctoral studentship from “Fonds de Recherche du Québec en Santé (FRQ-S)”.
Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model
Version of Record online: 16 MAY 2014
© 2014 International Parkinson and Movement Disorder Society
Volume 29, Issue 9, pages 1125–1133, August 2014
How to Cite
Mahmoudi, S., Lévesque, D. and Blanchet, P. J. (2014), Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model. Mov. Disord., 29: 1125–1133. doi: 10.1002/mds.25909
Relevant conflicts of interest/financial disclosures: Dr. Blanchet reports having received lecture fees from Novartis Pharma Canada Inc., and consultation fees from UCB Pharma. Dr. Mahmoudi and Dr. Lévesque declare no potential conflicts of interest.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue online: 18 AUG 2014
- Version of Record online: 16 MAY 2014
- Manuscript Accepted: 8 APR 2014
- Manuscript Revised: 24 MAR 2014
- Manuscript Received: 4 FEB 2014
Additional Supporting Information may be found in the online version of this article at the publisher's web-site.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.